description

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports

general info

  • Uploaded    05/21/2020
  • Business & Finance
  • Vaccines more relevant than China for investors: CIO
  • Stocks end mostly higher on Trump China comments
  • Fed's Powell to unemployed: We're here for you
  • UK helps employers with slow phase-in of job shield costs
  • Renault closes site, restructures in bid to slash costs
  • First successful flight for world's largest all-electric plane
  • 197 cars: all the UK could produce in April
  • IPO values coffee maker JDE Peet's at $17.3bln
  • Canopy Growth shares plummet